Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxorubicin PK in Pediatric Cancer
NCT01095926Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- May 2010
- Primary completion
- Feb 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 4
01
Overview
A Phase 2 trial of doxorubicin in Wilms' tumor, neuroblastoma, soft tissue sarcoma (STS), Ewing sarcoma, acute lymphoblastic leukemia (ALL), sponsored by Universitätsklinikum Münster. Started May 2010; status: completed.
02
Drugs
doxorubicin
03
Conditions
Wilms' tumorneuroblastomasoft tissue sarcoma (STS)Ewing sarcomaacute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01095926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01095926.